SIS
BIIB icon

Strategic Investment Solutions’s Biogen BIIB Stock Holding History

Strategic Investment Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$1.76K – 670
2025
Q4 		$1.76K Hold
10
– – ﹤0.01% 548
2025
Q3 		$1.4K Hold
10
– – ﹤0.01% 527
2025
Q2 		$1.26K Hold
10
– – ﹤0.01% 524
2025
Q1 		$1.37K Hold
10
– – ﹤0.01% 532
2024
Q4 		$2.59K Hold
10
– – ﹤0.01% 515
2024
Q3 		$1.94K Hold
10
– – ﹤0.01% 500
2024
Q2 		$2.13K Buy
+10
New +$2.17K ﹤0.01% 489
2023
Q4 		$2.59K Buy
+10
New +$2.46K ﹤0.01% 935
2023
Q2 		– Sell
-10
Closed -$2.78K – 878
2023
Q1 		$2.78K Buy
+10
New +$2.77K ﹤0.01% 829

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Strategic Investment Solutions's BIIB Position: Q1 2026 in Review

Strategic Investment Solutions sold out of Biogen (BIIB) in Q1 2026, closing a stake of 10 shares — an estimated $1.76K sold.

Strategic Investment Solutions first reported a position in BIIB in Q1 2023 and held it in 9 quarters. The position peaked at $2.78K in Q1 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Strategic Investment Solutions reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Strategic Investment Solutions sold 10 Biogen shares in Q1 2026, an estimated $1.76K.
  • Strategic Investment Solutions first reported a position in Biogen in Q1 2023 and held it in 9 quarters.
  • Strategic Investment Solutions's Biogen position peaked at $2.78K in Q1 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Strategic Investment Solutions's 13F filing for Q1 2026, filed 1 May 2026.